FDG PET/CT (FDG PET) in evaluation of response in patients with multiple myeloma (MM) treated with bortezomib, pegylated liposomal doxorubicin, and dexamethasone Meeting Abstract


Authors: Pandit-Taskar, N.; Comenzo, R. L.; Hassoun, H.; Hoover, E.; Borkar, S.; Reidel, E.; Cohen, A.; Surti, C.; Nimer, S. D.; Landau, H. J.
Abstract Title: FDG PET/CT (FDG PET) in evaluation of response in patients with multiple myeloma (MM) treated with bortezomib, pegylated liposomal doxorubicin, and dexamethasone
Meeting Title: 45th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 27
Issue: 15 Suppl.
Meeting Dates: 2009 May 29-Jun 2
Meeting Location: Orlando, FL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2009-05-20
Start Page: 442s
Language: English
ACCESSION: WOS:000276606605442
PROVIDER: wos
Notes: Meeting Abstract: 8533 -- Source: Wos
MSK Authors
  1. Adam D Cohen
    42 Cohen
  2. Raymond L Comenzo
    112 Comenzo
  3. Hani Hassoun
    146 Hassoun
  4. Stephen D Nimer
    344 Nimer
  5. Heather Jolie Landau
    180 Landau
  6. Elizabeth Hoover
    19 Hoover
  7. Sunita Anirudh Borkar
    6 Borkar
  8. Chirag Surti
    2 Surti
Related MSK Work